Plain-English translation of NCT06870435 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Nasopharyngeal cancer is a rare cancer in most places, but it occurs more frequently in certain regions like southern China. Researchers want to find the most accurate and practical way to screen people for early signs of this cancer using blood tests and nasal swabs, rather than jumping straight to invasive procedures like endoscopy and biopsy.
Current screening methods for nasopharyngeal cancer use antibody blood tests, but doctors don't know whether adding new markers—like checking for viral DNA directly in the blood or testing antibodies produced in response to specific virus proteins—could catch more cases while reducing unnecessary invasive procedures and costs.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn to test for virus-related markers and provide a nasal swab sample. The study will compare two screening strategies: a simpler one-step approach where all tests happen at once, or a two-step approach where you first get initial blood tests, and only if those are positive, you move to additional testing. Those identified as high-risk may need an endoscopy (a camera examination of the throat) with or without a biopsy. You will be followed over time to see if the screening methods accurately identify who develops cancer.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China